Progranulin protein levels in cerebrospinal fluid in primary neurodegenerative dementias

Estrella Morenas-Rodríguez, Laura Cervera-Carles, Eduard Vilaplana, Daniel Alcolea, María Carmona-Iragui, Oriol Dols-Icardo, Roser Ribosa-Nogué, Laia Muñoz-Llahuna, Isabel Sala, M. Belén Sánchez-Saudinós, Rafael Blesa, Jordi Clarimón, Juan Fortea, Alberto Lleó

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)

Abstract

© 2016 - IOS Press and the authors. Background: Progranulin is implicated in frontotemporal dementia (FTD), but its role in other neurodegenerative disorders is unknown. Objective: To investigate the levels of progranulin (PGRN) in cerebrospinal fluid (CSF) in different neurodegenerative dementias and their correlation with levels in plasma in cognitively normal subjects. Methods:We measured PGRN in CSF in 229 patients with amnestic mild cognitive impairment, Alzheimer's disease dementia, sporadic FTD, dementia with Lewy bodies, corticobasal syndrome, or progressive supranuclear palsy.We also measured PGRN in CSF and plasma in 74 cognitively normal individuals. We examined the correlation between PGRN levels in CSF and diagnosis, cortical thickness, genetic factors and other CSF biomarkers. We also investigated the correlation between plasma and CSF levels of PGRN in cognitively normal individuals. Results: CSF levels did not differ across diagnoses or correlate with cortical thickness. Polymorphism rs5848 in GRN influenced CSF PGRN levels, but APOE ε4 allele did not. Amyloid-β42, t-tau, p-tau, and YKL-40 levels correlated weakly with PGRN in CSF. We found a weak correlation (r = 0.362) between plasma and CSF PGRN levels in cognitively normal individuals. Conclusions: Our findings do not support a diagnostic value of CSF PGRN in neurodegenerative diseases. Our data confirm that levels of PGRN in plasma do not reflect accurately levels in CSF in cognitively normal controls. These data should be considered in clinical trials aiming to increase PGRN.
Original languageEnglish
Pages (from-to)539-546
JournalJournal of Alzheimer's Disease
Volume50
Issue number2
DOIs
Publication statusPublished - 10 Jan 2016

Keywords

  • Alzheimer's disease
  • amyloid-β
  • biomarker
  • cerebrospinal fluid
  • dementia
  • plasma
  • progranulin
  • tau

Fingerprint Dive into the research topics of 'Progranulin protein levels in cerebrospinal fluid in primary neurodegenerative dementias'. Together they form a unique fingerprint.

  • Cite this

    Morenas-Rodríguez, E., Cervera-Carles, L., Vilaplana, E., Alcolea, D., Carmona-Iragui, M., Dols-Icardo, O., Ribosa-Nogué, R., Muñoz-Llahuna, L., Sala, I., Belén Sánchez-Saudinós, M., Blesa, R., Clarimón, J., Fortea, J., & Lleó, A. (2016). Progranulin protein levels in cerebrospinal fluid in primary neurodegenerative dementias. Journal of Alzheimer's Disease, 50(2), 539-546. https://doi.org/10.3233/JAD-150746